Globeflex Capital’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Globeflex Capital’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-123,555	Closed	-$1.21M	–	612
2015 Q2	$1.21M	Sell	123,555 -26,583	-18%	-$242K	0.22%	165
2015 Q1	$1.33M	Buy	150,138 +3	+0%	+$24	0.25%	143
2014 Q4	$1.31M	Buy	150,135 +149,733	+37,247%	+$1.21M	0.25%	142
2014 Q3	$3K	Buy	402 +134	+50%	+$803	﹤0.01%	399
2014 Q2	$1K	Buy	+268	New	+$1.3K	﹤0.01%	568
2013 Q4	–	Sell	-256,278	Closed	-$1.3M	–	710
2013 Q3	$1.3M	Sell	256,278 -10,400	-4%	-$57.9K	0.17%	170
2013 Q2	$1.32M	Buy	+266,678	New	+$1.27M	0.18%	148

Other funds holding SCLN

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

Globeflex Capital's SCLN Position: Q3 2015 in Review

Globeflex Capital sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2015, closing a stake of 123,555 shares — an estimated $1.21M sold.

Globeflex Capital first reported a position in SCLN in Q2 2013 and held it in 7 quarters. The position peaked at $1.33M in Q1 2015. 134 funds tracked by Wall St. Rank hold SCLN as of Q3 2015.

Globeflex Capital reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
Globeflex Capital sold 123,555 Sciclone Pharmaceuticals Inc shares in Q3 2015, an estimated $1.21M.
Globeflex Capital first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
Globeflex Capital's Sciclone Pharmaceuticals Inc position peaked at $1.33M in Q1 2015.
134 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2015.

Based on Globeflex Capital's 13F filing for Q3 2015, filed 9 Nov 2015.